These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
189 related items for PubMed ID: 4797284
1. Pharmacology of oxytocin-(1-6)-hexapeptide amide, vasopressin-(1-6)-hexapeptide amide and their deamino analogues. Krejcí I, Barth T, Kupková B, Fruhaufová L, Flegel M, Zaoral M. Eur J Pharmacol; 1973 Nov; 24(2):179-82. PubMed ID: 4797284 [No Abstract] [Full Text] [Related]
2. Pharmacology of cyclic analogues of deamino-oxytocin not containing a disulphide bond (carba analogues). Barth T, Krejcí I, Kupková B, Jost K. Eur J Pharmacol; 1973 Nov; 24(2):183-8. PubMed ID: 4797285 [No Abstract] [Full Text] [Related]
3. Effect of an amide group in place of the disulfide bridge in deamino-oxytocin. Hase S, Sakakibara S, Wahrenburg M, Walter R. J Med Chem; 1972 Oct; 15(10):1017-9. PubMed ID: 4672192 [No Abstract] [Full Text] [Related]
4. Crystalline deamino-dicarba-oxytocin. Preparation and some pharmacological properties. Yamanaka T, Hase S, Sakakibara S, Schwartz IL, Dubois BM, Walter R. Mol Pharmacol; 1970 Sep; 6(5):474-80. PubMed ID: 5466703 [No Abstract] [Full Text] [Related]
5. [Vasopressin and Oxytocin. Physiological and pharmacological basis for the clinical use of the posterior pituitary gland hormones]. Rauch R. Dtsch Med Wochenschr; 1969 Dec 12; 94(50):2611-4. PubMed ID: 4901915 [No Abstract] [Full Text] [Related]
6. Solid phase synthesis of (1-deamino,4-valine)-8-D-arginine-vasopressin (DVDAVP), a highly potent and specific antidiuretic agent possessing protracted effects. Manning M, Balaspiri L, Acosta M, Sawyer WH. J Med Chem; 1973 Sep 12; 16(9):975-8. PubMed ID: 4745513 [No Abstract] [Full Text] [Related]
7. [Potentiation of the effects of oxytocin and vasopressin by the magnesium ion on the smooth muscle of isolated rat uterus]. Ishida Y, Moritoki H. Nihon Yakurigaku Zasshi; 1966 Nov 20; 62(6):398-403. PubMed ID: 6008361 [No Abstract] [Full Text] [Related]
8. Synthesis and some of the pharmacological properties of (4-leucine)-8-lysine-vasopressin and (1-deamino,4-leucine)-8-lysine-vasopressin. Dyckes DF, Ferger MF, Du Vigneaud V, Chan WY. J Med Chem; 1973 Jul 20; 16(7):843-7. PubMed ID: 4725931 [No Abstract] [Full Text] [Related]
9. Synthesis and some pharmacological properties of 8-L-homoarginine-vasopressin and of 1-deamino-8-L-homoarginine-vasopressin. Lindeberg G, Bodanszky M, Acosta M, Sawyer WH. J Med Chem; 1974 Jul 20; 17(7):781-3. PubMed ID: 4836417 [No Abstract] [Full Text] [Related]
13. The effects of oxytocin and vasopressin during the oestrous cycle and pregnancy on the uterus of a marsupial species, the quokka (Setonix brachyurus). Heller H. J Endocrinol; 1973 Sep 20; 58(3):657-71. PubMed ID: 4743540 [No Abstract] [Full Text] [Related]
14. Synthetic antagonists of the myometrial response to vasopressin and oxytocin. Melin P, Trojnar J, Johansson B, Vilhardt H, Akerlund M. J Endocrinol; 1986 Oct 20; 111(1):125-31. PubMed ID: 3783079 [Abstract] [Full Text] [Related]
18. Synthesis and certain pharmacological properties of lysine-vasopressinoic acid methylamide and lysine-vasopressinoic acid dimethylamide. Glass JD, du Vigneaud V. J Med Chem; 1972 May 20; 15(5):486-8. PubMed ID: 5064318 [No Abstract] [Full Text] [Related]